Labrox selected for the 2016 CEBR hotlist

We are proud and happy to bring you the following newsflash:

March 18, 2016, Labrox Oy was selected for the 2016 Medical Device SME Hotlist from the Council of European BioRegions.

Reasons for the appointment are:

Labrox Oy launched a lateral flow reader prototype based on strips and Upcon technology at Medica in November 2015. Labrox Oy, in partnership with Kaivogen Oy, two Finnish life science companies, introduced the Upcon™ Upconverting nanoparticle system featuring a new addition into the reader-family designed especially for lateral flow applications. The revolutionary technology enables lateral flow assays with ELISA sensitivity.

January 15th 2016 also saw Labrox receive its second patent on the company’s ground breaking dynamic filter storage carousel with positive filter ID tracking. The patent approval no.125682, ”Apparatus and Method for measuring of optical component” can identify filters by actually measuring the spectral properties of a unknown filter (Finland patent. EU submitted).

Click here for the Medica news release
Click here for patent information.

About the CEBR Medical Device Directory and Hotlist:

The Council of European BioRegions asbl brings together over 60 SMEs from 11 clusters across Europe in a rapidly growing online directory dedicated to the development of medical devices. Launched in June 2016, the focus of the directory is on SMEs as developers of their own components or complete devices and has the aim to create a centralised hub for investors and partners to find the right SMEs for global development and distribution. The 2016 Hotlist celebrates 10 SMEs that have made substantial scientific or business progress since the directory launch in 2016. It was generated through nominations from the clusters participating in the directory. The Directory and Hotlist is sponsored in 2016 by Teijin Pharma Ltd.

Useful links:
· Medical Device Directory:
· Medical Device SME Hotlist:
· April 11 webinar and registration: